PTGS2 and eosinophilia-myalgia syndrome: The occurrence of EMs was associated with the increase of cyclooxygenase-2 (COX-2), vascular endothelial growth factor (VEGF) and tumor necrosis factor alpha (TNF-α) contents as well as changes in NF-κB signal pathway.